Murine cytomegalovirus protein pM79 is a key regulator for viral late transcription

Journal of Virology

Volumn 87, Issue 16, 2013, Pages 9135-9147

  Chapa, Travis J ^a   Steven Johnson, L ^a   Affolter, Christopher ^b   Valentine Mark C , M C ^b   Fehr, Anthony R ^a   Yokoyama, Wayne M ^b,c   Yu, Dong ^a  

^a Department of Molecular Microbiology ^*  (United States)

^b Division of Rheumatology   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

M79 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA STRUCTURE; DNA SYNTHESIS; DOWN REGULATION; EMBRYO; FIBROBLAST; GENE FUNCTION; GENE IDENTIFICATION; GENE PRODUCT; IMMEDIATE EARLY GENE; M79 GENE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PULSED FIELD GEL ELECTROPHORESIS; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; VIROGENESIS; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WILD TYPE;

ANIMALS; CELL NUCLEUS; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, VIRAL; GENE KNOCKOUT TECHNIQUES; MICE; MUROMEGALOVIRUS; TRANSCRIPTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84881257705     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00688-13     Document Type: Article

References (49)

1. Britt WJ, Alford CA. 1996. Cytomegalovirus, p 2493-2523. In Fields BN, Knipe DM, Howley PM (ed), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, PA.
2. Crough T, Khanna R. 2009. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 22:76-98.
3. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. 1992. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N. Engl. J. Med. 326:663-667.
4. Selik RM, Chu SY, Ward JW. 1995. Trends in infectious diseases and cancers among persons dying of HIV infection in the United States from 1987 to 1992. Ann. Intern. Med. 123:933-936.
5. Reddehase MJ, Simon CO, Seckert CK, Lemmermann N, Grzimek NK. 2008. Murine model of cytomegalovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 325:315-331.
6. Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA. 2007. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol. Cell Biol. 85:46-54.
7. Rawlinson WD, Farrell HE, Barrell BG. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
8. Johnson PA, Everett RD. 1986. DNA replication is required for abundant expression of a plasmid-borne late US11 gene of herpes simplex virus type 1. Nucleic Acids Res. 14:3609-3625.
9. Mavromara-Nazos P, Roizman B. 1987. Activation of herpes simplex virus 1 gamma 2 genes by viral DNA replication. Virology 161:593-598.
10. Mocarski ES, Shenk T, Pass RF. 2007. Cytomegaloviruses, p 2701-2772. In Knipe DM, Howley PM (ed), Fields virology, 5th ed, vol 2. Lippincott Williams & Wilkins, Philadelphia, PA.
11. Chen J, Silverstein S. 1992. Herpes simplex viruses with mutations in the gene encoding ICP0 are defective in gene expression. J. Virol. 66:2916- 2927.
12. Poffenberger KL, Raichlen PE, Herman RC. 1993. In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutant. Virus Genes 7:171-186.
13. Rice SA, Knipe DM. 1990. Genetic evidence for two distinct transactivation functions of the herpes simplex virus alpha protein ICP27. J. Virol. 64:1704-1715.
14. Smith CA, Bates P, Rivera-Gonzalez R, Gu B, DeLuca NA. 1993. ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. J. Virol. 67:4676-4687.
15. Zabierowski S, DeLuca NA. 2004. Differential cellular requirements for activation of herpes simplex virus type 1 early (tk) and late (gC) promoters by ICP4. J. Virol. 78:6162-6170.
16. Zhu Z, Schaffer PA. 1995. Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27. J. Virol. 69:49-59.
17. Depto AS, Stenberg RM. 1992. Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation. J. Virol. 66:3241- 3246.
18. Johnson PA, Everett RD. 1986. The control of herpes simplex virus type-1 late gene transcription: a "TATA-box"/cap site region is sufficient for fully efficient regulated activity. Nucleic Acids Res. 14:8247-8264.
19. McWatters BJ, Stenberg RM, Kerry JA. 2002. Characterization of the human cytomegalovirus UL75 (glycoprotein H) late gene promoter. Virology 303:309-316.
20. Alba MM, Das R, Orengo CA, Kellam P. 2001. Genomewide function conservation and phylogeny in the Herpesviridae. Genome Res. 11:43-54.
21. Isomura H, Stinski MF, Kudoh A, Murata T, Nakayama S, Sato Y, Iwahori S, Tsurumi T. 2008. Noncanonical TATA sequence in the UL44 late promoter of human cytomegalovirus is required for the accumulation of late viral transcripts. J. Virol. 82:1638-1646.
22. Leach FS, Mocarski ES. 1989. Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J. Virol. 63:1783-1791.
23. Serio TR, Cahill N, Prout ME, Miller G. 1998. A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle. J. Virol. 72:8338-8343.
24. Arumugaswami V, Wu TT, Martinez-Guzman D, Jia Q, Deng H, Reyes N, Sun R. 2006. ORF18 is a transfactor that is essential for late gene transcription of a gammaherpesvirus. J. Virol. 80:9730-9740.
25. Isomura H, Stinski MF, Murata T, Yamashita Y, Kanda T, Toyokuni S, Tsurumi T. 2011. The human cytomegalovirus gene products essential for late viral gene expression assemble into prereplication complexes before viral DNA replication. J. Virol. 85:6629-6644.
26. Perng YC, Qian Z, Fehr AR, Xuan B, Yu D. 2011. The human cytomegalovirus gene UL79 is required for the accumulation of late viral transcripts. J. Virol. 85:4841-4852.
27. Kinsella TM, Nolan GP. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7:1405-1413.
28. Baird GS, Zacharias DA, Tsien RY. 2000. Biochemistry, mutagenesis, and oligomerization of DsRed, a red fluorescent protein from coral. Proc. Natl. Acad. Sci. U. S. A. 97:11984-11989.
29. Warming S, Costantino N, Court DL, Jenkins NA, Copeland NG. 2005. Simple and highly efficient BAC recombineering using galK selection. Nucleic Acids Res. 33:e36. doi:10.1093/nar/gni035.
30. Paredes AM, Yu D. 2012. Human cytomegalovirus: bacterial artificial chromosome (BAC) cloning and genetic manipulation. Curr. Protoc Microbiol. Chapter 14:Unit 14E.14. doi:10.1002/9780471729259.mc14e04s24.
31. Harvey DM, Levine AJ. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5:2375-2385.
32. Wagner M, Jonjic S, Koszinowski UH, Messerle M. 1999. Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. J. Virol. 73:7056-7060.
33. Busche A, Angulo A, Kay-Jackson P, Ghazal P, Messerle M. 2008. Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med. Microbiol. Immunol. 197:233-240.
34. Cardin RD, Abenes GB, Stoddart CA, Mocarski ES. 1995. Murine cytomegalovirus IE2, an activator of gene expression, is dispensable for growth and latency in mice. Virology 209:236-241.
35. Manning WC, Mocarski ES. 1988. Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology 167:477-484.
36. Xuan B, Qian Z, Torigoi E, Yu D. 2009. Human cytomegalovirus protein pUL38 induces ATF4 expression, inhibits persistent JNK phosphorylation, and suppresses endoplasmic reticulum stress-induced cell death. J. Virol. 83:3463-3474.
37. Wheat RL, Clark PY, Brown MG. 2003. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. J. Virol. Methods 112:107-113.
38. Cheng TP, Valentine MC, Gao J, Pingel JT, Yokoyama WM. 2010. Stability of murine cytomegalovirus genome after in vitro and in vivo passage. J. Virol. 84:2623-2628.
39. Stein LD, Mungall C, Shu S, Caudy M, Mangone M, Day A, Nickerson E, Stajich JE, Harris TW, Arva A, Lewis S. 2002. The generic genome browser: a building block for a model organism system database. Genome Res. 12:1599-1610.
40. Qian Z, Xuan B, Hong TT, Yu D. 2008. The full-length protein encoded by human cytomegalovirus gene UL117 is required for the proper maturation of viral replication compartments. J. Virol. 82:3452-3465.
41. Bai Y, Trang P, Li H, Kim K, Zhou T, Liu F. 2008. Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA. Proc. Natl. Acad. Sci. U. S. A. 105:10919-10924.
42. Loutsch JM, Galvin NJ, Bryant ML, Holwerda BC. 1994. Cloning and sequence analysis of murine cytomegalovirus protease and capsid assembly protein genes. Biochem. Biophys. Res. Commun. 203:472-478.
43. Yu D, Silva MC, Shenk T. 2003. Functional map of human cytomegalovirus AD169 defined by global mutational analysis. Proc. Natl. Acad. Sci. U. S. A. 100:12396-12401.
44. Penfold ME, Mocarski ES. 1997. Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis. Virology 239:46-61.
45. Lacaze P, Forster T, Ross A, Kerr LE, Salvo-Chirnside E, Lisnic VJ, Lopez-Campos GH, Garcia-Ramirez JJ, Messerle M, Trgovcich J, Angulo A, Ghazal P. 2011. Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes. J. Virol. 85:6065-6076.
46. Marcinowski L, Lidschreiber M, Windhager L, Rieder M, Bosse JB, Radle B, Bonfert T, Gyory I, de Graaf M, Prazeres da Costa O, Rosenstiel P, Friedel CC, Zimmer R, Ruzsics Z, Dolken L. 2012. Realtime transcriptional profiling of cellular and viral gene expression during lytic cytomegalovirus infection. PLoS Pathog. 8:e1002908. doi:10.1371 /journal.ppat.1002908.
47. Liang Y, Vogel JL, Narayanan A, Peng H, Kristie TM. 2009. Inhibition of the histone demethylase LSD1 blocks alpha-herpesvirus lytic replication and reactivation from latency. Nat. Med. 15:1312-1317.
48. Lieberman PM. 2008. Chromatin organization and virus gene expression. J. Cell. Physiol. 216:295-302.
49. Sinclair J. 2010. Chromatin structure regulates human cytomegalovirus gene expression during latency, reactivation and lytic infection. Biochim. Biophys. Acta 1799:286-295.